AKT1 and COVID-19: According to GO and KEGG enrichment analysis, the mechanisms for naringenin treatment of COVID-19/LUSC may be related to oxidative stress, immunoregulation, apoptosis, antiviral, anti-inflammatory, anti-cancer, and associated signaling pathways such as PI3K-Akt, HIF-1, and VEGF.